Tower Research Capital LLC (TRC) - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 14 filers reported holding TRANSCODE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2
-50.0%
6,3510.0%0.00%
Q4 2022$4
-99.9%
6,351
+15.4%
0.00%
Q3 2022$6,000
-25.0%
5,505
-8.5%
0.00%
Q2 2022$8,000
+33.3%
6,017
+204.7%
0.00%
Q1 2022$6,0000.0%1,975
-15.2%
0.00%
Q4 2021$6,000
+50.0%
2,329
+58.1%
0.00%
Q3 2021$4,0001,4730.00%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders